Ovid Therapeutics reported cash from operations of -$17.60M and free cash flow of -$17.60M for the quarter ended Jun 2026, down 268.7% year over year. This cash flow statement covers 42 quarters of results from Mar 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||||
| Net Income | -11.38M | -26.00M | -16.11M | -14.59M | -11.97M | -11.50M | -13.36M | -12.41M | -11.25M | -15.32M | -11.69M | 8.52M | -14.01M | -9.25M | -10.23M | -4.68M | -12.16M | 9.66M | -16.99M | -15.01M | ||||||||||||||||||||||
| Share-based CompensationStock Comp. | 10.68M | 1.32M | 15.78M | 0.01M | 1.92M | 1.95M | 1.63M | 1.79M | 1.97M | 1.74M | 1.31M | 1.26M | 1.28M | 1.22M | 1.11M | 1.20M | 1.05M | 1.43M | ||||||||||||||||||||||||
| Deferred Taxes | ||||||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -10.87M | -12.00M | -20.09M | -13.29M | -12.68M | -9.18M | -12.11M | -11.71M | -10.05M | -11.91M | -16.69M | -14.26M | -15.01M | -10.01M | -10.28M | -4.77M | -12.87M | -10.41M | -13.90M | -17.60M | ||||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.35M | 0.26M | 0.25M | 0.25M | 0.26M | 0.26M | 0.26M | 0.27M | 0.27M | 0.28M | 0.28M | 0.29M | 0.29M | 0.30M | 0.30M | 0.31M | 0.32M | |||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.05M | 0.06M | 0.07M | 0.10M | 0.16M | 0.18M | 0.14M | 0.14M | 0.15M | 0.14M | 0.14M | 0.15M | 0.17M | 0.16M | 0.14M | 0.10M | 0.02M | 0.02M | 0.04M | 0.02M | ||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 2.09M | -4.87M | 2.36M | -3.58M | 0.92M | -0.12M | 1.93M | -2.55M | 2.49M | -0.11M | 1.12M | -2.01M | 0.48M | -1.24M | 2.00M | -2.24M | 0.25M | 3.62M | -1.51M | |||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -3.43M | 0.75M | 0.30M | -3.37M | 1.10M | -1.19M | -0.42M | 1.35M | 0.79M | 0.30M | -2.49M | 4.07M | -0.54M | -1.58M | -0.00M | -3.15M | 0.03M | 2.05M | -1.40M | -0.35M | ||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.16M | 0.05M | 1.04M | 0.02M | 0.12M | 0.01M | 0.10M | -0.01M | 0.02M | 0.10M | -0.03M | ||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 30.00M | 60.00M | 40.00M | 45.00M | 25.00M | 10.00M | 30.00M | 50.00M | 10.00M | 38.00M | 10.00M | 17.00M | 10.00M | 5.00M | 10.00M | 16.00M | ||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.06M | -0.16M | -1.08M | -80.68M | -1.96M | -4.17M | 30.23M | 20.07M | -4.36M | -48.52M | 20.19M | 12.82M | 0.29M | 21.29M | 5.10M | 12.05M | 5.05M | -72.06M | 5.95M | -86.74M | ||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.46M | 0.31M | 0.03M | 0.11M | 0.08M | -0.04M | 0.07M | 0.21M | 0.22M | 0.03M | 0.23M | 0.36M | 0.04M | 0.01M | 0.01M | 75.09M | 59.80M | -3.62M | ||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.55M | 0.11M | 0.03M | 0.11M | 0.08M | -0.04M | 0.07M | 0.21M | 0.22M | 30.03M | 0.23M | 0.36M | 0.04M | 0.01M | 0.01M | 75.18M | 88.98M | 21.60M | ||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.05M | 2.43M | ||||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.02M | 2.37M | 0.00M | |||||||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.12M | -0.00M | ||||||||||||||||||||||||||||||||||||||||
| Change in Cash | -10.39M | -12.05M | -21.13M | -93.86M | -14.56M | -13.39M | 18.18M | 8.57M | -14.19M | -30.39M | 3.73M | -1.08M | -14.68M | 11.28M | -5.17M | 7.28M | -7.80M | -7.46M | 80.91M | -82.74M | ||||||||||||||||||||||
| Free Cash FlowFCF | -10.88M | -12.16M | -20.13M | -14.33M | -12.69M | -9.30M | -12.13M | -11.80M | -10.05M | -11.90M | -16.70M | -14.35M | -15.01M | -9.98M | -10.28M | -4.77M | -12.87M | -10.41M | -13.90M | -17.60M | ||||||||||||||||||||||
| Net Cash FlowNCF | -10.39M | -12.05M | -21.13M | -93.86M | -14.56M | -13.39M | 18.18M | 8.57M | -14.19M | -30.39M | 3.73M | -1.08M | -14.68M | 11.28M | -5.17M | 7.28M | -7.80M | -7.29M | 81.03M | -82.74M |